Breast Cancer Clinical Trial
— e-DomSantéOfficial title:
Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté)
Observational study about patients treated for a metastasis breast cancer who live far from their comprehensive cancer center and followed by telemedicine, connected wtaches and patient-reported symptom monitoring.
Status | Recruiting |
Enrollment | 15 |
Est. completion date | February 2018 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Women more than 18 years old - Treated for an advanced metastasis breast cancer - Who live far from their comprehensive cancer center in the Landes department Exclusion Criteria: - Women who are not able to understand the study because of psychiatric disease |
Country | Name | City | State |
---|---|---|---|
France | Institut Bergonie | Bordeaux |
Lead Sponsor | Collaborator |
---|---|
Institut Bergonié | Région Nouvelle Aquitaine |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quality of life of the patients | FACT-B questionnary | 3 months | |
Primary | Quality of life of the patients | FACT-B questionnary | 6 months | |
Primary | Quality of life of the patients | FACT-B questionnary | 9 months | |
Primary | Quality of life of the patients | FACT-B questionnary | 12 months | |
Primary | Quality of life of the patients | FACT-B questionnary | 15 months | |
Primary | Quality of life of the patients | FACT-B questionnary | 18 months | |
Primary | Quality of life of the patients | FACT-B questionnary | 21 months | |
Primary | Quality of life of the patients | FACT-B questionnary | 24 months | |
Secondary | How patients feel about the study | General questionnary for satisfaction | 3 months | |
Secondary | How patients feel about the study | General questionnary for satisfaction | 6 months | |
Secondary | How patients feel about the study | General questionnary for satisfaction | 9 months | |
Secondary | How patients feel about the study | General questionnary for satisfaction | 12 months | |
Secondary | How patients feel about the study | General questionnary for satisfaction | 15 months | |
Secondary | How patients feel about the study | General questionnary for satisfaction | 18 months | |
Secondary | How patients feel about the study | General questionnary for satisfaction | 21 months | |
Secondary | How patients feel about the study | General questionnary for satisfaction | 24 months | |
Secondary | Number of consultation via telemedicine | CRF done for each consultation | through study completion, an average of 24 months | |
Secondary | Quality of sound and image quality | CRF done for each consultation | through study completion, an average of 24 months | |
Secondary | Medical actions after telemedicine | CRF done for each consultation | through study completion, an average of 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Recruiting |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |